#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Neurotrophic keratopathy Round cell liposarcoma Endometrial adenocarcinoma Multifocal motor neuropathy Hairy cell leukaemia Autoimmune disorder Cystic fibrosis respiratory infection suppression Necrotising myositis Ovarian epithelial cancer Malignant neoplasm of choroid Thrombocytopenia Gastroenteropancreatic neuroendocrine tumour disease PIK3CA related overgrowth spectrum Follicle centre lymphoma follicular grade I II – III refractory More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Treatment Mitochondrial myopathy – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Noonan syndrome – Life with Disease Carcinoid syndrome – Treatment Haemophilia A with anti factor VIII Hereditary angioedema Myelodysplastic syndrome with excess blasts – Life with Disease Prolymphocytic leukaemia Myxofibrosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-23B-116 Ivermectin Iclepertin Motixafortide Palivizumab AZD5335 Tradipitant Nanatinostat Darunavir Vancomycin Aficamten METHYLPHENIDATE Tremelimumab Vidutolimod HYDROGEN PEROXIDE Alitretinoin Flucloxacillin Metoclopramide Hydrochloride Idarubicin AZD0022 More therapies…

    Learn about Your Condition

    Small fibre neuropathy Triple negative breast cancer Oedema Ewing's sarcoma Hydrocephalus Carcinoid syndrome Head and neck cancer stage III Vulvovaginal discomfort Scoliosis Chorioretinitis Prolymphocytic leukaemia Endometrial cancer stage I Precocious puberty Multiple system atrophy Lichen sclerosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Transmural Healing in Patients with Moderate to Severe Crohn’s Disease Using Upadacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Risankizumab
    • Adalimumab
    Belgium Denmark France Germany Italy The Netherlands +2

  • Study on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Meningioma malignant
    Investigated Drugs:
    • Regorafenib
    Italy

  • Study on the Effectiveness and Safety of Riliprubart Compared to Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Riliprubart
    Belgium Czechia Denmark France Germany Greece +7

  • Study on Sarilumab and Etanercept for Rheumatoid Arthritis in Patients Not Responding to csDMARD Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sarilumab
    • Etanercept
    Belgium Germany Italy The Netherlands Portugal Spain

  • Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Ro7589655
    Italy Poland Spain

  • Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Capecitabine
    • Dostarlimab
    • Fluorouracil
    Belgium Czechia Estonia Finland France Germany +8

  • Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated Drugs:
    • (Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate
    Austria Belgium France Germany Hungary Italy +1

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Calcium Levofolinate
    • Fluorouracil
    France Italy

  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic gastritis
    Investigated Drugs:
    • Dupilumab
    France Italy Poland

  • Study on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • CHLOROQUINE PHOSPHATE
    • Dazukibart
    • Deflazacort
    Belgium Bulgaria France Germany Hungary Italy +4
Previous Page
1 … 24 25 26 27 28 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!